leticia corrales
Aduro BioTech (United States)
Berkeley, United States
Review Editor
Cancer Immunity and Immunotherapy
Aduro BioTech (United States)
Berkeley, United States
Review Editor
Cancer Immunity and Immunotherapy
UnitĂ di Oncologia Medica, Azienda ospedaliera 'Bianchi-Melacrino-Morelli'
Reggio Calabria, Italy
Review Editor
Cancer Immunity and Immunotherapy
Ludwig Institute for Cancer Research, Centre Hospitalier Universitaire Vaudois (CHUV)
Lausanne, Switzerland
Review Editor
Cancer Immunity and Immunotherapy
Department of Pathology, Oslo University Hospital
Oslo, Norway
Review Editor
Cancer Immunity and Immunotherapy
University Hospital Bonn
Bonn, Germany
Review Editor
Cancer Immunity and Immunotherapy
University of Perugia
Perugia, Italy
Review Editor
Cancer Immunity and Immunotherapy
Queen's University
Kingston, Canada
Review Editor
Cancer Immunity and Immunotherapy
Institut National de la Santé et de la Recherche Médicale (INSERM)
Paris, France
Review Editor
Cancer Immunity and Immunotherapy
The University of Queensland
Brisbane, Australia
Review Editor
Cancer Immunity and Immunotherapy
University of Southampton
Southampton, United Kingdom
Review Editor
Cancer Immunity and Immunotherapy
Queen's University
Kingston, Canada
Review Editor
Cancer Immunity and Immunotherapy
University of Toledo Medical Center
Toledo, United States
Review Editor
Cancer Immunity and Immunotherapy
CHU Sainte Justine Research Center, University of Montreal
Montréal, Canada
Review Editor
Cancer Immunity and Immunotherapy
Independent researcher
London, United Kingdom
Review Editor
Cancer Immunity and Immunotherapy
Laboratory Animal Biotechnology Unit, Institut Pasteur de Montevideo
Montevideo, Uruguay
Review Editor
Cancer Immunity and Immunotherapy
University Clinic of Navarra
Pamplona, Spain
Review Editor
Cancer Immunity and Immunotherapy